Tacrine

Drug Profile

Tacrine

Alternative Names: CI 970; Cognex

Latest Information Update: 27 Apr 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Pfizer
  • Class Aminoacridines; Antidementias; Small molecules
  • Mechanism of Action Acetylcholinesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Alzheimer's disease
  • Discontinued HIV infections

Most Recent Events

  • 18 Apr 2016 ProStrakan is now called Kyowa Kirin International
  • 21 Apr 2011 ProStrakan has been acquired by Kyowa Hakko Kirin
  • 12 Jan 2010 Sciele Pharma is now called Shionogi Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top